caused by pathogen or bacteria is estimated to drive market growth. Rise in the number of incidence related to genetic
disorders, solid tumors, leukemia, autism, and other syndromes are predicted to stimulate market demand for In Situ
hybridization over the forecast period.
The market is broadly categorized into major four segments based on the product type such as instruments, kits & probes,
software and services. The instruments is considered as one of the fastest growing segment in the In Situ hybridization
market with substantial revenue generation in the last few years. Growing popularity of the instruments segment among
healthcare professionals is attributed to the rise in the demand from diagnostic and research laboratories. The kits &
probes segment has also witnessed substantial growth owing to the growing incidence of target disorders such as cancer.
The market is divided by region as North America, Europe, Asia-Pacific, Latin America and Africa. North America has
shown major growth in recent years owing to the rise in the implementation of latest technologies in pharmaceuticals &
medicine sector, higher penetration rates, increase in the demand for disposable devices from healthcare professionals,
and existence of well-established infrastructure.
Asia-Pacific region is predicted to hold major market share in the In Situ hybridization market with massive growth in
forecast period. Countries such as India, China and Singapore are leading the Asia-Pacific market with increasing
healthcare expenditure, growing prevalence of cancer related diseases, presence of high-unmet patient needs, and
significant investment by leading industry players considering potential growth opportunities in the region.
The key players in the In Situ hybridization market are Thermo Fisher Scientific Co., Leica BiosystemsNussloch GmbH,
BIOVIEW, Inc., Agilent Technologies, Inc., Merck KGaA, PerkinElmer, Inc., Bio-Rad Laboratories, Inc.,
NeoGenomics Laboratories, Inc., Advanced Cell Diagnostics, Inc., and Oxford Gene Technology Co.
Get a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/in-situ-hybridization-ish-
market-share/request-sample
Market Segment:
Market Leaders
• Leica Biosystems Nussloch GmbH
• Thermo Fisher Scientific
• F. Hoffmann-La Roche AG
• Abbott Laboratories
• Agilent Technologies
• PerkinElmer
• Qiagen / Exiqon A/S